Company intelligence / Profile preview

Arrowtown

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Arrowtown is a private investment firm and limited partnership primarily focused on the life sciences and biotechnology sectors. The firm operates as an investment vehicle for high-net-worth individuals and institutional capital, often participating in venture financing rounds for innovative healthcare companies. Arrowtown is notably associated with the investment activities of Richard Kayne and Propel Bio Partners, contributing to the development of late-stage clinical assets and emerging biotech platforms. Most recently, the firm participated in the Series A financing for EIT Pharma to support the advancement of infectious disease therapies.

Industry: Investors

Partnerships

Propel Bio PartnersGood Ventures

Beyond the preview

Go deeper on Arrowtown.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arrowtown.

Explore the full profile